Weight-loss, diabetes drugs linked to vision problems in small study
GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.
New drug delivery method promises long-lasting glaucoma relief
Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...
Daily Express US on MSN2d
Ozempic and Zepbound linked to rare eye conditions that could cause blindness
A new study suggests popular weight-loss drugs like Ozempic and Zepbound may be linked to rare eye conditions that could ...
abc273d
Child welfare agencies are buckling under staffing shortages as Pa. debates using opioid money to help
Ed Mahon reported this story while participating in the USC Annenberg Center for Health Journalism’s 2024 Data Fellowship and received engagement mentoring and funding. Spotlight PA is ...
Poor sleep and addiction go hand in hand − understanding how could lead to new treatments for opioid use disorder
A good night’s sleep often sets the stage for a positive day. But for the nearly quarter of American adults struggling with ...